Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Net Margin (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Net Margin readings, the most recent being 10.79% for Q4 2025.

  • On a quarterly basis, Net Margin fell 989.0% to 10.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 26.66%, a 12.0% increase, with the full-year FY2025 number at 26.66%, up 12.0% from a year prior.
  • Net Margin hit 10.79% in Q4 2025 for Treace Medical Concepts, up from 32.62% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 0.9% in Q4 2024 to a low of 57.51% in Q2 2022.
  • Median Net Margin over the past 5 years was 30.82% (2022), compared with a mean of 28.39%.
  • Biggest five-year swings in Net Margin: tumbled -3271bps in 2022 and later soared 2803bps in 2023.
  • Treace Medical Concepts' Net Margin stood at 19.79% in 2021, then soared by 55bps to 8.86% in 2022, then decreased by -16bps to 10.25% in 2023, then soared by 91bps to 0.9% in 2024, then plummeted by -1098bps to 10.79% in 2025.
  • The last three reported values for Net Margin were 10.79% (Q4 2025), 32.62% (Q3 2025), and 36.97% (Q2 2025) per Business Quant data.